ID

33811

Beschreibung

A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis C; ODM derived from: https://clinicaltrials.gov/show/NCT01250743

Link

https://clinicaltrials.gov/show/NCT01250743

Stichworte

  1. 28.12.18 28.12.18 -
  2. 28.12.18 28.12.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

28. Dezember 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hepatitis C NCT01250743

Eligibility Hepatitis C NCT01250743

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
hepatitis c, genotype 1
Beschreibung

Hepatitis C virus genotype determination

Datentyp

boolean

Alias
UMLS CUI [1]
C1533728
failed treatment with interferon-alpha and ribavirin
Beschreibung

Interferon-alpha failed | Ribavirin failed

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0002199
UMLS CUI [1,2]
C0231175
UMLS CUI [2,1]
C0035525
UMLS CUI [2,2]
C0231175
abstain from alcohol consumption for the duration of the study
Beschreibung

Avoidance Alcohol consumption

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0870186
UMLS CUI [1,2]
C0001948
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
cirrhosis
Beschreibung

Liver Cirrhosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0023890
decompensated liver disease
Beschreibung

Decompensated liver disease

Datentyp

boolean

Alias
UMLS CUI [1]
C4075847
glucose6phosphate dehydrogenase deficiency
Beschreibung

Deficiency of glucose-6-phosphate dehydrogenase

Datentyp

boolean

Alias
UMLS CUI [1]
C2939465
ast or alt more than 5 times upper limit of normal
Beschreibung

Aspartate aminotransferase increased | Alanine aminotransferase increased

Datentyp

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
platelets less than 125,000
Beschreibung

Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
diabetes mellitus
Beschreibung

Diabetes Mellitus

Datentyp

boolean

Alias
UMLS CUI [1]
C0011849
alcohol and/or drug abuse within 1 year of screening
Beschreibung

Substance Use Disorders

Datentyp

boolean

Alias
UMLS CUI [1]
C0038586

Ähnliche Modelle

Eligibility Hepatitis C NCT01250743

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis C virus genotype determination
Item
hepatitis c, genotype 1
boolean
C1533728 (UMLS CUI [1])
Interferon-alpha failed | Ribavirin failed
Item
failed treatment with interferon-alpha and ribavirin
boolean
C0002199 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C0035525 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
Avoidance Alcohol consumption
Item
abstain from alcohol consumption for the duration of the study
boolean
C0870186 (UMLS CUI [1,1])
C0001948 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Liver Cirrhosis
Item
cirrhosis
boolean
C0023890 (UMLS CUI [1])
Decompensated liver disease
Item
decompensated liver disease
boolean
C4075847 (UMLS CUI [1])
Deficiency of glucose-6-phosphate dehydrogenase
Item
glucose6phosphate dehydrogenase deficiency
boolean
C2939465 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
ast or alt more than 5 times upper limit of normal
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Platelet Count measurement
Item
platelets less than 125,000
boolean
C0032181 (UMLS CUI [1])
Diabetes Mellitus
Item
diabetes mellitus
boolean
C0011849 (UMLS CUI [1])
Substance Use Disorders
Item
alcohol and/or drug abuse within 1 year of screening
boolean
C0038586 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video